Publikace
- Screening of Synthetic Heterocyclic Compounds as Antiplatelet Drugs2022 | Farmaceutická fakulta v Hradci Králové
- Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine2022 | Farmaceutická fakulta v Hradci Králové
- 4-Methylcatechol, a Flavonoid Metabolite with Potent Antiplatelet Effects2019 | Farmaceutická fakulta v Hradci Králové
- The influence of microbial isoflavonoid specific metabolites on platelets and transition metals iron and copper2019 | Farmaceutická fakulta v Hradci Králové
- The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo2019 | Farmaceutická fakulta v Hradci Králové
- Comprehensive review of cardiovascular toxicity of drugs and related agents2018 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- 9-(4'-dimethylaminophenyl)-2,6,7-trihydroxy-xanthene-3-one is a Potentially Novel Antiplatelet Drug which Antagonizes the Effect of Thromboxane A(2)2018 | Farmaceutická fakulta v Hradci Králové
- Interaction of soy isoflavones and their main metabolites with hOATP2B1 transporter2018 | Farmaceutická fakulta v Hradci Králové
- Two flavonoid metabolites, 3,4-dihydroxyphenylacetic acid and 4-methylcatechol, relax arteries ex vivo and decrease blood pressure in vivo2018 | Farmaceutická fakulta v Hradci Králové
- The isoflavonoid tectorigenin has better antiplatelet potential than acetylsalicylic acid2017 | Farmaceutická fakulta v Hradci Králové
Loading network view...